HIGHLIGHTS
- who: Report and colleagues from the Department of Physiology, National and Kapodistrian University of Athens, Athens, GRC Second Department of have published the article: Review began 12/02/2022 Review ended 12/10/2022 Published 12/14/2022 u00a9 Copyright, in the Journal: (JOURNAL) of February/26,/2020
- what: Concluding, our case regards an immunocompromised multiple_sclerosis patient under a rituximab treatment regimen whose COVID-19 presented with prolonged clinical symptomatology along with extended persistence of viral shedding, as proven by repeated viral RT-PCR on nasopharyngeal specimen swabs.
SUMMARY
A 49 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.